Song Mu
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Cancer Research top 10%
- Genetics top 10%
- Co-authors
- Weimin ZhaoJie ZhangHaijiang WangWenyi QinYouqin XuJing ChenZhiming WangPaul G. Richardson
- Topics
- PARP inhibition in cancer therapy (10 papers)Multiple Myeloma Research and Treatments (7 papers)Histone Deacetylase Inhibitors Research (6 papers)
- Cited by
- HematologyCancer ResearchGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Song Mu
46 papers receiving 891 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 536
- Oncology 244
- Hematology 192
- Cancer Research 190
- Genetics 121
Countries citing papers authored by Song Mu
This map shows the geographic impact of Song Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Mu more than expected).
Fields of papers citing papers by Song Mu
This network shows the impact of papers produced by Song Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Mu. The network helps show where Song Mu may publish in the future.
Co-authorship network of co-authors of Song Mu
This figure shows the co-authorship network connecting the top 25 collaborators of Song Mu. A scholar is included among the top collaborators of Song Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Song Mu. Song Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | 68 | |
| 7 | 29 | |
| 8 | 8 | |
| 9 | 7 | |
| 10 | 7 | |
| 11 | 89 | |
| 12 | 25 | |
| 13 | 41 | |
| 14 | 16 | |
| 15 | 13 | |
| 16 | 31 | |
| 17 | 21 | |
| 18 | 21 | |
| 19 | 36 | |
| 20 | 16 |
About Song Mu
Song Mu is a scholar working on Hematology, Genetics and Physiology, having authored 49 papers that have together received 909 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Hematology (192 citations), Cancer Research (190 citations) and Genetics (121 citations). Song Mu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weimin Zhao, Jie Zhang, Haijiang Wang, Wenyi Qin, Youqin Xu, Jing Chen, Zhiming Wang, Paul G. Richardson, David S. Siegel and Jesús F. San Miguel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.